Combined therapy with desferrioxamine and deferiprone: A new protocol for iron chelation in thalassemia

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 7, 2004, Pages 451-453

  D'Angelo, Emanuela ^a,b   Mirra, Nadia ^a   Rocca, Alice ^a   Carnelli, Vittorio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Clinica Pediatrica   (Italy)

Author keywords

Beta thalassemia; Deferiprone; Desferrioxamine; Iron chelation

Indexed keywords

ALANINE AMINOTRANSFERASE; DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON CHELATION; IRON URINE LEVEL; MALE; METAPLASIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SIDE EFFECT; SKIN FIBROSIS; THALASSEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; CHILD; DEFEROXAMINE; DRUG THERAPY, COMBINATION; FEMALE; FERRITINS; HUMANS; IRON; IRON CHELATING AGENTS; MALE; THALASSEMIA;

EID: 3543058868     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200407000-00011     Document Type: Article

References (11)

1. Olivieri NF, Brittenham GM. Iron chelating therapy and the treatment of thalassemia. Blood. 1997;89:739-755.
2. Araujo A, Kosaryan M, MacDowell A, et al. A novel delivery system for continuous desferrioxamine infusion in transfusional iron overload. Br J Haematol. 1996;93:835-837.
3. Hoffbrand AV, Wonke B. Iron chelation therapy. J Intern Med. 1997;740(Suppl):37-41.
4. Olivieri NF, Brittenham GM, Matsui D, et al. Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med. 1995;332:918-922.
5. Cohen A, Galanello R, Piga A, et al. A multicenter safety trial of the oral iron chelator deferiprone. Ann NY Acad Sci. 1998;850:223-226.
6. Kontoghiorghes GJ, Aldouri MA, Hoffbrand AV, et al. Effective chelation of iron in β-thalassemia with the oral chelator 1,2-dimethyl-3- hydroxypyrid-4-one. Br Med J. 1987;295:1509-1512.
7. Barlett AN, Hoffbrand AV, Kontoghiorghes GJ. Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1): clinical observations. Br J Haematol. 1990;76:301-304.
8. Wonke B, Wright C, Hoffbrand AV. Combined therapy with deferiprone and desferrioxamine. Br J Haematol. 1998;103:361-364.
9. Aydinok Y, Nisli G, Kavakli K, et al. Sequential use of deferiprone and desferrioxamine in primary school children with thalassaemia major in Turkey. Acta Haematol. 1999;102:17-21.
10. Grady RW, Berdoukas V, Giardina PJ. Iron chelation: combined therapy could be a better approach. Blood. 1998;92(Suppl 1):16b-17b.
11. Mourad FH, Hoffbrand AV, Sheikh-Taha M. Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients. Br J Haematol. 2003;121:187-189.